Opportunity to join the imaging cardiology group at @LHCHFT , consultant cardiologist with specialist interest in structural imaging job advert is here ➡️ https://t.co/mmrgbXHZCP @robcoops82 @fairbairn_tim @VPettemerides @Sarah_Moharem @ClareCulshaw1

High intensity exercise can improve cardiorespiratory fitness, reduce cardiovascular risk and provide psychological benefit in individuals with hypertrophic cardiomyopathy. However, for these positive effects to have a lasting impact, regular exercise must become a consistent

I've spent almost a decade championing exercise in my ICC patients and am so proud to see this article providing a practical approach to exercise prescription in patients with cardiomyopathies and channelopathies published in @Heart_BMJ today. I hope that this article empowers

📣 Substantive EP & Devices consultant post now advertising in the world renowned Liverpool Heart and Chest Hospital @LHCHFT @LiverpoolEP Looking especially for candidates to support the clinical & academic structural heart VT programme Apply now👇 https://t.co/DU4RNuuFET

‼️Echo Vacancy‼️ We are looking for Highly Specialised Cardiac Physiologist in Echocardiography! https://t.co/qUrCmC6BQR

#AICC conference November 11th-12th 2024! We hope you can join us in Cambridge for 2 days of ICC updates, networking opportunities and dinner with friends 😊 https://t.co/pddZOgoPQN @AiccUk @eleanorwicks @BehrElijah #CardioTwitter #CardioEd

https://t.co/RRS0OVnuxU

Cardiomyopathy UK national training day being held in Liverpool 21/10/24. Delegate places extended due to popular demand! Sign up here:

#Aficamten 1/6 presentation. Follow along Here are the results of the #SEQUOIA #HCM #whyCMR substudy (aficamten vs placebo on oHCM) which is also simultaneously published in @JACCJournals #CardioTwitter

ICC fellow post now available with the team at LHCH, access to post CCT training in all aspects of ICC with time for developing subspecialist interests in imaging/EP/Devices. Please get in contact if you are interested!

📖 Learn more about established and novel therapeutic interventions in patients with obstructive #HypertrophicCardiomyopathy, with a focus on percutaneous and surgical strategies 👉 https://t.co/FeA5ceo09Z #HCM #CJC

#4 - Prof. David Oxborough -How Steroids Affect your Heart

Interested in the Scientist Training Programme (STP)? Register for our online open day on the 18th Jan to hear from various specialisms about why you should apply to Barts Health! @DrNolanStain @THspiro @Mammacoffee @mdstbarts @ahcsuk @BartsCardiac

A cardiac arrest can occur at any time to anyone - which is why we're pleased to share details of @FootballFoundtn's @PremierLeague Defibrillator Fund, which supports the installation of AEDs at grassroots facilities. Learn more 👉 https://t.co/22CfAfX2Vw

Interventions in Hypertrophic Obstructive Cardiomyopathy - ScienceDirect

Our first publication from our bodybuilder cohort - anabolic steroid use causes bi-atrial dilatation and reduced reservoir and conduit function. ⁦@LJMUSportSci⁩ ⁦@robcoops82⁩ ⁦@KPGeorge66⁩ ⁦⁦@BarbMorrison9⁩ ⁦@BSEcho⁩

Our latest publication https://t.co/vACTCSTR5i the role of echocardiography in the assessment of the athletes heart....its multi-factorial #echofirst @LJMUSportSci @DrAneilMalhotra @KPGeorge66 @paton_maria @shaunrobinson02 @DanXAugustine @robcoops82

Further expansion of the ICC unit at LHCH, another consultant post available. Feel free to contact us for more information.

📢 Big step forward for cardiomyopathy drug 📢 NICE, has published their final draft guidance on Mavacamten, recommending that Mavacamten is made available for treating symptomatic obstructive HCM in adults. Learn more:

More data to suggest blanket exercise restriction in HCM may not be warranted. Patient selection is important but in this population vigorous exercise did not increase risk of cardiac events. That’s before considering the beneficial effects of exercise!